These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 6364801
1. Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis. Thomas MR, Robinson WA, Dantas M, Koeppler H, Drebing C, Glode LM. Am J Hematol; 1984 Feb; 16(2):105-12. PubMed ID: 6364801 [Abstract] [Full Text] [Related]
2. Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan. Matulonis UA, Griffin JD, Canellos GP. Am J Hematol; 1994 Apr; 45(4):283-7. PubMed ID: 7909981 [Abstract] [Full Text] [Related]
3. A dose intensive regimen of cytosine arabinoside and daunorubicin for chronic myelogenous leukemia in blast crisis. Kouides PA, Rowe JM. Leuk Res; 1995 Oct; 19(10):763-70. PubMed ID: 7500655 [Abstract] [Full Text] [Related]
4. Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML. Anger B, Heimpel H. Blut; 1989 Jun; 58(6):299-301. PubMed ID: 2660927 [Abstract] [Full Text] [Related]
5. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ. N Engl J Med; 1996 May 30; 334(22):1428-34. PubMed ID: 8618581 [Abstract] [Full Text] [Related]
9. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernik PH. N Engl J Med; 1998 Dec 03; 339(23):1649-56. PubMed ID: 9834301 [Abstract] [Full Text] [Related]
10. Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases. Lemonnier MP, Gorin NC, Laporte JP, Douay L, Lopez M, van den Akker J, Stachowiak J, David R, Pene F, Kantor G. Exp Hematol; 1986 Aug 03; 14(7):654-8. PubMed ID: 3525203 [Abstract] [Full Text] [Related]
12. Autologous bone-marrow and peripheral blood buffy coat cell infusion in the treatment of chronic myeloid and acute leukemia. Mahmood T, Robinson WA, Entringer M. Exp Hematol; 1979 Aug 03; 7 Suppl 5():321-6. PubMed ID: 400695 [Abstract] [Full Text] [Related]
14. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia. Amadori S, Picardi A, Fazi P, Testi AM, Petti MC, Montefusco E, Mandelli F. Leukemia; 1996 May 03; 10(5):766-8. PubMed ID: 8656669 [Abstract] [Full Text] [Related]
15. Treatment of chronic myelogenous leukemia in blast crisis and in accelerated phase with high- or intermediate-dose cytosine arabinoside and amsacrine. Bauduer F, Delmer A, Blanc MC, Delmas-Marsalet B, Cadiou M, Rio B, Marie JP, Zittoun R. Leuk Lymphoma; 1993 Jun 03; 10(3):195-200. PubMed ID: 8220118 [Abstract] [Full Text] [Related]
16. Chronic myelogenous leukemia: a clinical and experimental evaluation of splenectomy and intensive chemotherapy. Brodsky I, Fuscaldo KE, Kahn SB, Conroy JF, Lamping CG. Ser Haematol; 1975 Jun 03; 8(4):143-56. PubMed ID: 798283 [No Abstract] [Full Text] [Related]
20. Effect of early splenectomy and cyclic acute leukemia-like chemotherapy on the course of chronic myeloid leukemia. Baccarani M, Guolo ML, Tura S. Boll Ist Sieroter Milan; 1978 Jul 31; 57(3):360-9. PubMed ID: 282906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]